Jazz Pharmaceuticals JAZZ Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's net change in cash?
- Jazz Pharmaceuticals (JAZZ) reported net change in cash of $452.4M in Q1 2026.
- How has Jazz Pharmaceuticals's net change in cash changed year-over-year?
- Jazz Pharmaceuticals's net change in cash increased by 182.1% year-over-year, from -$551M to $452.4M.
- What is the long-term trend for Jazz Pharmaceuticals's net change in cash?
- Over 3 years (2021 to 2024), Jazz Pharmaceuticals's net change in cash has grown at a 24.8% compound annual growth rate (CAGR), from -$466.32M to $906.55M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.